Clinical reference Biomarker Directory
Back to directory

MB

Established

Myoglobin is an early but nonspecific muscle injury marker, now mainly used to gauge rhabdomyolysis severity.

Also known as Myoglobin
In plain language

Myoglobin rises very quickly after muscle damage, but it can't tell whether the damage is in the heart or elsewhere in the body, which is why troponin has largely replaced it for diagnosing heart attacks. It's still useful for judging how severe a muscle-breakdown injury (rhabdomyolysis) is.

Biomarker & context

Myoglobin is an oxygen-binding protein found in cardiac and skeletal muscle; it is released early after muscle injury, making it one of the fastest-rising (though least specific) markers of muscle or cardiac damage.

What it indicates

Elevated myoglobin indicates muscle injury of some kind (cardiac or skeletal) but cannot distinguish between the two sources, and its cardiac diagnostic role has been almost entirely superseded by troponin, which is far more specific for heart muscle injury.

Diagnosis & clinical testing

Measured via serum immunoassay; myoglobin's main remaining clinical utility is in rhabdomyolysis assessment, where markedly elevated levels (alongside CK) help gauge the severity of muscle breakdown and associated kidney injury risk from myoglobin's toxic effects on renal tubules.

Guiding treatment

In suspected rhabdomyolysis, aggressive IV fluid resuscitation is guided partly by the degree of myoglobin/CK elevation, aiming to prevent myoglobin-induced acute kidney injury.

Clinical significance

Its cardiac diagnostic role has been superseded by the far more specific troponin.

References
  1. General cardiology and nephrology reference literature on myoglobin in rhabdomyolysis and its historical cardiac diagnostic role.